ArticleQatar medical journal2026
Neurological fallout of hyperglycemia: A case report of a rare presentation of osmotic demyelination syndrome.
Article in Qatar medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: : Osmotic demyelination syndrome (ODS) is a rare but potentially life-threatening neurological disorder. It is characterized by non-inflammatory demyelination, usually triggered by sudden shifts in serum osmolality. However, emerging evidence suggests that abrupt osmotic shifts caused by severe hyperglycemia, even in the absence of sodium imbalance, can also precipitate ODS. Case presentation: : A 57-year-old male with poorly controlled type 2 diabetes mellitus and chronic alcohol use presented with recurrent seizures and altered sensorium. Initial blood work revealed severe hyperglycemia (390 mg/dL), an elevated HbA1c level (15.2%), and a normal corrected serum sodium level (135 mEq/L). During hospitalization, the patient developed progressive neurological deterioration, culminating in quadriplegia. Imaging findings: : Initial non-contrast computed tomography (NCCT) of the brain was unremarkable. Magnetic resonance imaging (MRI) on day 11 showed symmetric T2/FLAIR (Fluid-Attenuated Inversion Recovery) hyperintensities in the central pons extending into the middle cerebellar peduncles. These findings, in the absence of diffusion restriction or enhancement, were characteristic of central pontine myelinolysis (CPM). No extrapontine involvement was observed. Differential diagnosis: : Radiological differentials considered included acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), ischemic infarction, vasculitis, and brainstem glioma. However, the symmetric pontine involvement without enhancement or mass effect, along with the clinical context of hyperosmolar hyperglycemia, favored a diagnosis of ODS. Management and outcome: : Supportive therapy involving careful glucose correction, intravenous hydration, and close monitoring of metabolic parameters was initiated. The patient showed gradual neurological recovery during the hospital course. Conclusion: : This case highlights a rare presentation of CPM secondary to hyperosmolar hyperglycemia in the absence of hyponatremia. It underscores the importance of early recognition, neuroimaging, and cautious metabolic correction in diabetic patients presenting with new-onset neurological deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.